Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7WXU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,675
Award facts
- Contract value 100% obligated
- $32,675.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,675.39 to AmerSourceBergen Drug Corp for the supply of Ondansetron Oral Disintegrating Tablet 4 mg in quantities of 30 tablets. This firm fixed-price, non-set-aside contract was competitively awarded on January 29, 2026, with an ultimate completion date of January 30, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is a commonly prescribed antiemetic medication used to prevent nausea and vomiting, particularly in military and veteran healthcare settings supported by the Defense Logistics Agency's medical supply operations.
This delivery order is issued under AmerSourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9 billion prime contract vehicle that extends through December 2031. The IDC provides a comprehensive pharmaceutical supply mechanism enabling AmerSourceBergen to deliver a broad spectrum of medical commodities, including specialty medications, generic and brand-name drugs, vaccines, and medical supplies to support military healthcare programs globally. AmerSourceBergen's federal contract portfolio demonstrates significant capability and capacity to serve Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible, competitively awarded contract mechanisms.
Quick answers
Who was awarded contract SPE2DR26F7WXU?
SPE2DR26F7WXU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F7WXU worth?
The government has obligated $32,675 on SPE2DR26F7WXU.
Is contract SPE2DR26F7WXU an order under another contract?
Yes. SPE2DR26F7WXU is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WXU competed?
The extent of competition for SPE2DR26F7WXU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award